Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271K Sell
65,730
-76,769
-54% -$339K 0.03% 762
2026
Q1
$514K Buy
142,499
+84,785
+147% +$293K 0.06% 312
2025
Q4
$197K Buy
57,714
+37,248
+182% +$181K 0.02% 989
2025
Q3
$139K Buy
+20,466
New +$169K 0.02% 1141
2025
Q2
Sell
-21,670
Closed -$118K 1991
2025
Q1
$118K Sell
21,670
-11,019
-34% -$62.5K 0.02% 1091
2024
Q4
$162K Buy
32,689
+7,635
+30% +$40K 0.02% 962
2024
Q3
$131K Buy
25,054
+19,881
+384% +$115K 0.02% 964
2024
Q2
$35.5K Sell
5,173
-16,943
-77% -$155K 0.01% 1457
2024
Q1
$227K Buy
22,116
+5,516
+33% +$40.8K 0.04% 514
2023
Q4
$138K Buy
+16,600
New +$119K 0.03% 786

Other funds holding LFMD

State of Wyoming's LFMD Position: Q2 2026 in Review

State of Wyoming reduced its LifeMD (LFMD) stake by 54% in Q2 2026, selling an estimated $339K and leaving 65,730 shares worth $271K. The position accounts for 0.03% of the portfolio, ranked #762.

State of Wyoming first reported a position in LFMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $514K in Q1 2026. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • State of Wyoming held 65,730 shares of LifeMD worth $271K as of Q2 2026.
  • State of Wyoming sold 76,769 LifeMD shares in Q2 2026, an estimated $339K.
  • LifeMD made up 0.03% of State of Wyoming's portfolio in Q2 2026, its #762 holding.
  • State of Wyoming first reported a position in LifeMD in Q4 2023 and has held it in 10 quarters since.
  • State of Wyoming's LifeMD position peaked at $514K in Q1 2026.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.